Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Medtronic backs out of $738M deal | Cardiologist at center of alleged scheme | Dapagliflozin & HF symptoms

News You Need to Know Today
Medtronic backs out of $738M deal | Cardiologist at center of alleged scheme | Dapagliflozin & HF symptoms
Friday, December 8, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Medtronic backs out of $738M acquisition due to ‘multiple breaches’

Medtronic confirmed its decision in a statement, but did not provide any specific details. The deal was originally announced in May.

READ MORE >
artificial intelligence money finance acquisition
Share on Twitter Share on Facebook Share on Linkedin

Medtronic backs out of $738M acquisition due to ‘multiple breaches’

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence money finance acquisition
Medtronic confirmed its decision in a statement, but did not provide any specific details. The deal was originally announced in May.
READ MORE >

Kentucky health system, cardiologist to pay $3M for alleged scheme targeting Medicare and Medicaid

The alleged scheme involved a series of diagnostic procedures that, according to the U.S. government, were not medically necessary. 

READ MORE >
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
Share on Twitter Share on Facebook Share on Linkedin

Kentucky health system, cardiologist to pay $3M for alleged scheme targeting Medicare and Medicaid

Share on Twitter Share on Facebook Share on Linkedin
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
The alleged scheme involved a series of diagnostic procedures that, according to the U.S. government, were not medically necessary. 
READ MORE >

Dapagliflozin improves symptoms in some, but not all, heart failure patients

The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

Dapagliflozin improves symptoms in some, but not all, heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent. 
READ MORE >

American College of Cardiology names renowned cardiologist the next editor-in-chief of its flagship journal

The publication's current editor-in-chief is Valentin Fuster, MD, PhD. Harlan M. Krumholz, MD, will begin his five-year term in 2024.

READ MORE >
The American College of Cardiology (ACC) has announced that Harlan M. Krumholz, MD, Yale, a veteran cardiologist known for his groundbreaking research abilities, will be the new editor-in-chief of the Journal of the American College of Cardiology (JACC) for a 5-year term.
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology names renowned cardiologist the next editor-in-chief of its flagship journal

Share on Twitter Share on Facebook Share on Linkedin
The American College of Cardiology (ACC) has announced that Harlan M. Krumholz, MD, Yale, a veteran cardiologist known for his groundbreaking research abilities, will be the new editor-in-chief of the Journal of the American College of Cardiology (JACC) for a 5-year term.
The publication's current editor-in-chief is Valentin Fuster, MD, PhD. Harlan M. Krumholz, MD, will begin his five-year term in 2024.
READ MORE >

Featured Articles

Plant-based vs. meat-based diets: Going vegan linked to better cardiovascular health in identical twin study

Researchers focused on 22 pairs of identical twins for 8 weeks, asking one twin to follow a healthy vegan diet and the other to follow a healthy omnivorous diet.

READ MORE >
doctor fruits vegetables vegetarian diet. Embracing a plant-based diet can improve a person’s cardiovascular health, according to a new commentary published in the American Journal of Cardiology.[1] The article, titled “Are We What We Eat? The Moral Imperative of the Medical Profession to Promote Plant-Based Nutrition,” also highlights multiple reasons that choosing plant-based nutrition over animal-based food can be viewed as being better for society as a whole.
Share on Twitter Share on Facebook Share on Linkedin

Plant-based vs. meat-based diets: Going vegan linked to better cardiovascular health in identical twin study

Share on Twitter Share on Facebook Share on Linkedin
doctor fruits vegetables vegetarian diet. Embracing a plant-based diet can improve a person’s cardiovascular health, according to a new commentary published in the American Journal of Cardiology.[1] The article, titled “Are We What We Eat? The Moral Imperative of the Medical Profession to Promote Plant-Based Nutrition,” also highlights multiple reasons that choosing plant-based nutrition over animal-based food can be viewed as being better for society as a whole.
Researchers focused on 22 pairs of identical twins for 8 weeks, asking one twin to follow a healthy vegan diet and the other to follow a healthy omnivorous diet.
READ MORE >

Cardiologists lead push for Aetna to reconsider ‘restrictive,’ ‘inconsistent’ reimbursement proposals

The policies cover a wide range of interventional therapies, including Shockwave Medical's IVL technology and intravascular ultrasound. 

READ MORE >
insurance
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists lead push for Aetna to reconsider ‘restrictive,’ ‘inconsistent’ reimbursement proposals

Share on Twitter Share on Facebook Share on Linkedin
insurance
The policies cover a wide range of interventional therapies, including Shockwave Medical's IVL technology and intravascular ultrasound. 
READ MORE >

Statin therapy benefits high-risk patients with no prior history of CVD

Two separate studies examined the controversial topic of prescribing statins to high-risk elderly patients who do not already have high cholesterol or cardiovascular disease.

READ MORE >
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Share on Twitter Share on Facebook Share on Linkedin

Statin therapy benefits high-risk patients with no prior history of CVD

Share on Twitter Share on Facebook Share on Linkedin
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Two separate studies examined the controversial topic of prescribing statins to high-risk elderly patients who do not already have high cholesterol or cardiovascular disease.
READ MORE >

In Case You Missed It

Medtronic gains 2 key approvals for its ablation portfolio

The company had good news to share about its highly anticipated PFA offering.

READ MORE >
Medtronic's PulseSelect Pulsed Field Ablation (PFA) System
Share on Twitter Share on Facebook Share on Linkedin

Medtronic gains 2 key approvals for its ablation portfolio

Share on Twitter Share on Facebook Share on Linkedin
Medtronic's PulseSelect Pulsed Field Ablation (PFA) System
The company had good news to share about its highly anticipated PFA offering.
READ MORE >

ADHD medications associated with heightened CVD risk

"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained. 

READ MORE >
Pills
Share on Twitter Share on Facebook Share on Linkedin

ADHD medications associated with heightened CVD risk

Share on Twitter Share on Facebook Share on Linkedin
Pills
"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained. 
READ MORE >

In Other News

Platform allowing patients to second-guess their radiologists’ findings expands to 12 states

MDView also has inked a new partnership with Modern Teleradiology to provide second opinion reports and video consultations to its users.

READ MORE >
Doctor patient tablet
Share on Twitter Share on Facebook Share on Linkedin

Platform allowing patients to second-guess their radiologists’ findings expands to 12 states

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient tablet
MDView also has inked a new partnership with Modern Teleradiology to provide second opinion reports and video consultations to its users.
READ MORE >

Credit forecast: Hospitals will recover only slowly from lingering ‘labor-demic’

In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.

READ MORE >
labor-demic hospitals staffing shortage
Share on Twitter Share on Facebook Share on Linkedin

Credit forecast: Hospitals will recover only slowly from lingering ‘labor-demic’

Share on Twitter Share on Facebook Share on Linkedin
labor-demic hospitals staffing shortage
In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib
News Alert: FDA shares new warning about Impella heart pumps after death
AHA takes on cardiac amyloidosis | Have clinicians been wrong about PAD? | FDA OKs new AI for heart failure
Insulin pods recalled | Cardiology groups support bill | Treating ‘broken hearts’ | AI delivers answers | Prasugrel after PCI
The high costs of robotic tech | Medtronic recalls thousands of devices | TAVR in younger patients | FDA approves next-gen valve

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …2
    • Page 3
    • Page 4
    • Page 5
    • Current page 6
    • Page 7
    • Page 8
    • Page 9
    • Page 10 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup